SARS-CoV-1 3CLPro in complex with N-(4-(1H-imidazol-4-yl)phenyl)-2-(1H-benzo[d][1,2,3]triazol-1-yl)… | | homo-2-mer | 3241-3546 | 4×GOL; 2×Y6G; 2×PEG; |
Assess |
X-ray Structure of SARS-CoV main protease covalently modified by compound GRL-0686 | | homo-2-mer | 3241-3546 | 2×4IO; 10×DMS; |
Assess |
SARS-CoV-1 3CLPro in complex with 2-(1H-benzo[d][1,2,3]triazol-1-yl)-N-(3-chlorobenzyl)-N-(4-(2-oxo… | | homo-2-mer | 3241-3546 | 4×PEG; 6×GOL; 2×Y67; |
Assess |
SARS-CoV-1 3CLPro in complex with N-(4-(1H-pyrazol-4-yl)phenyl)-2-(1H-benzo[d][1,2,3]triazol-1-yl)-… | | homo-2-mer | 3241-3546 | 4×GOL; 2×Y6A; |
Assess |
SARS-CoV-1 3CLPro in complex with 2-(1H-benzo[d][1,2,3]triazol-1-yl)-N-(4-(pyridin-3-yl)phenyl)-N-(… | | homo-2-mer | 3241-3546 | 2×Y6D; 4×GOL; |
Assess |
Crystal structure of the complex resulting from the reaction between the SARS-CoV main protease and… | | homo-2-mer | 3241-3546 | 2×OEW; 2×DMS; |
Assess |
Crystal structure of SARS-CoV 3C-like protease with C4Z | | homo-2-mer | 3241-3546 | 3×EDO; |
Assess |
Crystal structure of SARS-CoV 3C-like protease with M4Z | | homo-2-mer | 3241-3546 | 3×EDO; 1×GOL; |
Assess |
Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) 3CL Protease in Complex with N-[(1R)-2-(te… | | homo-2-mer | 3241-3546 | 2×0EN; 4×DMS; |
Assess |
Crystal structure of SARS coronavirus main protease complexed with Cm-FF-H (soaking) | | homo-2-mer | 3241-3546 | 2×S89; |
Assess |
Crystal structure of SARS-CoV 3C-like protease with B4Z | | homo-2-mer | 3241-3546 | 8×EDO; 1×GOL; |
Assess |
Crystal structure of SARS-CoV 3C-like protease in apo form | | homo-2-mer | 3241-3546 | 1×PEG; 7×EDO; |
Assess |
Structure of SARS 3CL protease with peptidic aldehyde inhibitor | | homo-2-mer | 3241-3546 | |
Assess |
Crystal structure of SARS-CoV 3C-like protease with C6Z | | homo-2-mer | 3241-3546 | 1×EDO; |
Assess |
Covalent complex of SARS-CoV main protease with 4-methoxy-N-[(2S)-4-methyl-1-oxo-1-({(2S)-3-oxo-1-[… | | homo-2-mer | 3242-3544 | 2×V3D; 1×EDO; |
Assess |
Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute … | | homo-2-mer | 3241-3542 | 2×23H; 4×DMS; |
Assess |
1.65 A resolution structure of SARS-CoV 3CL protease in complex with inhibitor 7j | | homo-2-mer | 3241-3542 | 2×VDJ; 2×QYS; |
Assess |
Structure of the SARS-CoV-1 main protease in complex with AG7404 | | homo-2-mer | 3241-3542 | 2×XNV; |
Assess |
Covalent complex of SARS-CoV main protease with N-[(2S)-1-({(2S,3S)-3,4-dihydroxy-1-[(3S)-2-oxopyrr… | | homo-2-mer | 3242-3542 | 2×V2M; |
Assess |
1.70 A resolution structure of SARS-CoV 3CL protease in complex with a deuterated GC376 alpha-ketoa… | | homo-2-mer | 3242-3542 | 2×CL; 2×VR4; 1×PG4; |
Assess |
X-Ray Crystal Structure of the SARS Coronavirus Main Protease | | homo-2-mer | 3241-3541 | 1×MPD; |
Assess |
Structure of SARS 3CL protease auto-proteolysis resistant mutant in the absent of inhibitor | | homo-2-mer | 3241-3541 | |
Assess |
Crystal structure of dimeric R298A mutant of SARS coronavirus main protease | | homo-2-mer | 3241-3541 | |
Assess |
Covalent complex of SARS-CoV main protease with ethyl (4R)-4-({N-[(4-methoxy-1H-indol-2-yl)carbonyl… | | homo-2-mer | 3242-3541 | 1×EDO; 2×V34; |
Assess |
1.85 A resolution structure of SARS-CoV 3CL protease in complex with deuterated GC376 | | homo-2-mer | 3241-3540 | 2×K36; 2×B1S; |
Assess |
Structure-Based Design, Synthesis, Evaluation of Peptide-mimetic SARS 3CL Protease Inhibitors | | homo-2-mer | 3241-3540 | |
Assess |
Crystal Structure of the F140A mutant of SARS-Coronovirus 3C-like Protease at pH 6.5 | | homo-2-mer | 3242-3541 | |
Assess |
Crystal Structure of the F140A mutant of SARS-Coronovirus 3C-like Protease at pH 7.6 | | homo-2-mer | 3241-3540 | |
Assess |
Crystal structure of SARS coronavirus main protease in complex with PF07304814 | | homo-2-mer | 3242-3540 | 2×80I; |
Assess |
Crystal Structure of the F140A mutant of SARS-Coronovirus 3C-like Protease at pH 6.0 | | homo-2-mer | 3242-3540 | |
Assess |
Mutation of Asn28 disrupts the enzymatic activity and dimerization of SARS 3CLpro | | homo-2-mer | 3243-3541 | |
Assess |
Crystal structure of SARS main protease in complex with inhibitor YH-53 | | homo-2-mer | 3242-3539 | 2×HUR; |
Assess |
Crystal structure of SARS main protease in complex with GC376 | | homo-2-mer | 3242-3539 | 2×UED; |
Assess |
Crystal structure of SARS coronavirus main protease in complex with an inhibitor Shikonin | | homo-2-mer | 3242-3539 | 1×FNO; |
Assess |
The co-crystal structure of Severe Acute Respiratory Syndrome Coronavirus 3C Like Protease with ald… | | monomer | 3241-3546 | 1×EOF; |
Assess |
The co-crystal structure of Severe Acute Respiratory Syndrome Coronavirus 3C-Like Protease with ald… | | monomer | 3241-3546 | 1×EOC; |
Assess |
Structure of SARS 3CL protease with peptidic aldehyde inhibitor containing cyclohexyl side chain | | monomer | 3241-3540 | |
Assess |
Crystal Structure of the S139A mutant of SARS-Coronovirus 3C-like Protease | | monomer | 3243-3539 | |
Assess |
NMR solution structure of C-terminal domain of SARS-CoV main protease in 2.5M urea | | monomer | 3427-3546 | |
Assess |